Next Article in Journal
Psychosocial and Economic Risks of Institutional Quarantine in a Low-Resource Setting: Experiences of Affected Persons during the COVID-19 Pandemic in Uganda
Previous Article in Journal
COVID-19 Pandemic Planning and Management: The Case of New Zealand General Practice Medical Centres
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

A Comprehensive Analysis of Structural and Functional Changes Induced by SARS-CoV-2 Spike Protein Mutations

by
Aganze Gloire-Aimé Mushebenge
1,2,*,
Samuel Chima Ugbaja
2,
Nonkululeko Avril Mbatha
3,
Rene B. Khan
2 and
Hezekiel M. Kumalo
2,*
1
Discipline of Pharmaceutical Sciences, University of KwaZulu-Natal, Westville, Durban 4000, South Africa
2
Drug Research and Innovation Unit, Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, University of KwaZulu-Natal, Durban 4000, South Africa
3
Africa Health Research Institute, University of KwaZulu-Natal, Durban 4000, South Africa
*
Authors to whom correspondence should be addressed.
COVID 2023, 3(9), 1454-1472; https://doi.org/10.3390/covid3090100
Submission received: 6 August 2023 / Revised: 10 September 2023 / Accepted: 14 September 2023 / Published: 16 September 2023

Abstract

The emergence of SARS-CoV-2, the virus responsible for the COVID-19 pandemic, has sparked intense research on its spike protein, which is essential for viral entrance into host cells. Viral reproduction and transmission, host immune response regulation, receptor recognition and host cell entrance mechanisms, as well as structural and functional effects have all been linked to mutations in the spike protein. Spike protein mutations can also result in immune evasion mechanisms that impair vaccine effectiveness and escape, and they are linked to illness severity and clinical consequences. Numerous studies have been conducted to determine the effects of these mutations on the spike protein structure and how it interacts with host factors. These results have important implications for the design and development of medicines and vaccines based on spike proteins as well as for the assessment of those products’ efficiency against newly discovered spike protein mutations. This paper gives a general overview of how spike protein mutations are categorized and named. It further looks at the links between spike protein mutations and clinical outcomes, illness severity, unanswered problems, and future research prospects. Additionally, explored are the effects of these mutations on vaccine effectiveness as well as the possible therapeutic targeting of spike protein mutations.
Keywords: SARS-CoV-2; spike protein; mutations; viral infectivity; pathogenesis; vaccine efficacy; immune evasion; antibody neutralization; T-cell response; therapeutic targeting SARS-CoV-2; spike protein; mutations; viral infectivity; pathogenesis; vaccine efficacy; immune evasion; antibody neutralization; T-cell response; therapeutic targeting

Share and Cite

MDPI and ACS Style

Mushebenge, A.G.-A.; Ugbaja, S.C.; Mbatha, N.A.; Khan, R.B.; Kumalo, H.M. A Comprehensive Analysis of Structural and Functional Changes Induced by SARS-CoV-2 Spike Protein Mutations. COVID 2023, 3, 1454-1472. https://doi.org/10.3390/covid3090100

AMA Style

Mushebenge AG-A, Ugbaja SC, Mbatha NA, Khan RB, Kumalo HM. A Comprehensive Analysis of Structural and Functional Changes Induced by SARS-CoV-2 Spike Protein Mutations. COVID. 2023; 3(9):1454-1472. https://doi.org/10.3390/covid3090100

Chicago/Turabian Style

Mushebenge, Aganze Gloire-Aimé, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, Rene B. Khan, and Hezekiel M. Kumalo. 2023. "A Comprehensive Analysis of Structural and Functional Changes Induced by SARS-CoV-2 Spike Protein Mutations" COVID 3, no. 9: 1454-1472. https://doi.org/10.3390/covid3090100

APA Style

Mushebenge, A. G.-A., Ugbaja, S. C., Mbatha, N. A., Khan, R. B., & Kumalo, H. M. (2023). A Comprehensive Analysis of Structural and Functional Changes Induced by SARS-CoV-2 Spike Protein Mutations. COVID, 3(9), 1454-1472. https://doi.org/10.3390/covid3090100

Article Metrics

Back to TopTop